Puma Biotechnology, Inc. (PBYI)
7.08
+0.03
(+0.43%)
USD |
NASDAQ |
May 22, 16:00
7.075
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology EPS Diluted (Quarterly) : -0.0738 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| AbbVie, Inc. | 0.3861 |
| Agios Pharmaceuticals, Inc. | -1.686 |
| Editas Medicine, Inc. | -0.2552 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.753M |
| Revenue (Quarterly) | 44.81M |
| Total Expenses (Quarterly) | 48.57M |
| Enterprise Value | 272.69M |
| Gross Profit Margin (Quarterly) | 76.74% |
| Profit Margin (Quarterly) | -8.37% |
| Earnings Yield | 6.74% |
| Operating Earnings Yield | 8.19% |
| Normalized Earnings Yield | 6.743 |